We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Eros | EROS | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 235.50 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 235.50 | 235.50 |
| Top Posts |
|---|
Posted at 08/5/2019 09:19 by planetgong I saw this on yahoofinuk:(Bloomberg) -- A Bollywood filmmaker that was spurned by credit investors several years ago is changing the terms on a planned dollar bond offering after money managers balked again, as signs of caution in global debt markets mount. Eros International Plc is tweaking its plan after holding road shows last month, at a time when investors have been inundated with dollar bond supply and U.S.-China trade tensions are bringing more volatility to markets. In a novel twist, the maker of films with stars such as Priyanka Chopra and Salman Khan now plans to offer notes that will be secured against its library of more than 12,000 film titles available to global viewers via its platform Eros Now, after having sought an unsecured structure last month, the company said when asked. It pulled a dollar bond offering two years ago after investors demanded higher yields. A surge in Asian dollar note sales is testing investor appetite after the market’s best rally in years. Buyers of Indian firms’ overseas debt have also faced issuance that has reached records in 2019. Last year, billionaire Mukesh Ambani’s Reliance Industries Ltd. acquired a 5 percent stake in Eros. The Mumbai-based company reported an unexpected quarterly profit. |
Posted at 06/10/2017 15:31 by smurfy2001 Eros International sues investors over market manipulation |
Posted at 31/3/2017 15:47 by smurfy2001 MUMBAI: In the past three months, the share price of media and entertainment company Eros International MediaBSE 1.59 % has gained a whopping 65% as opposed to 17.3% gain in ET Media Index. The sharp rise is on hopes of a possibility of fund raising by the company .However, such a sharp rise does not seem to reflect the company's lacklustre performance in the nine months to December 2016. Its revenue in this period fell by 7% year-onyear to Rs ,234 crore. In addition, the company's line up of films has not been impressive enough to evince such a high investor interest in the stock. The release date of one of its crucial Hindi film Sarkar 3 has been repeatedly postponed. There is also concern cited by analysts regarding its revolving credit facility payment. Under this arrangement, the company has a pay ment of $115 million due this month and it has been exploring options to raise funds. |
Posted at 15/11/2016 09:09 by blusteradjuster For the jam tomorrow investor - the key bits are below. It would help if they broke down those subscribers according to how much they contribute to EROS' top-line.Eros Now has 55 million registered users worldwide across WAP, App and Web. Eros Now has 1.32 million paying subscribers2, which represents 20% growth over last quarter. The Company believes that it remains on track to cross two million paying subscribers by the end of FY 2017. 2 Paying subscribers means any subscriber who has made a valid payment to subscribe to a service that includes the Eros Now service either as part of a bundle or on a standalone basis, either directly or indirectly through a telecom operator or OEM in any given month be it through a daily, weekly or monthly billing pack, as long as the validity of the pack is for at least one month. |
Posted at 10/10/2016 14:35 by rivaldo Increased institutional interest:"13F Action: Eros Intl Plc (EROS) Shareholder Paradice Investment Management LLC Has Boosted Its Holding October 10, 2016 Paradice Investment Management Llc increased its stake in Eros Intl Plc (EROS) by 20.26% based on its latest 2016Q2 regulatory filing with the SEC. Paradice Investment Management Llc bought 402,886 shares as the company’s stock rose 42.59% with the market. The institutional investor held 2.39 million shares of the movies and entertainment company at the end of 2016Q2, valued at $27.52M, up from 1.99M at the end of the previous reported quarter. Paradice Investment Management Llc who had been investing in Eros Intl Plc for a number of months, seems to be bullish on the $908.53 million market cap company. The stock closed at $15.85 during the last session. It is down 70.80% since March 7, 2016 and is uptrending. It has outperformed by 63.21% the S&P500. Paradice Investment Management Llc is a Colorado-based institutional investor with more than $705.02 million AUM in September, 2014....." |
Posted at 23/8/2016 01:03 by smurfy2001 Yeah i've been looking out for them too. Check later today.Tracking analyst recommendations and target prices may be an important part of stock analysis, but investors and analysts will most likely be keeping a watchful eye on company earnings reports as well. Covering analysts are currently expecting the company to report EPS of $0.14 for the quarter. For the last quarter, Eros International PLC (NYSE:EROS) reported an earnings per share actual of $0. This actual number came in $-0.02 off of the Zacks Research consensus estimate. The resulting surprise factor was -100%. The company is next projected to report earnings results on or around 2016-08-23. |
Posted at 22/8/2016 21:50 by markhowes Understood that 1st Quarter results were due last week but so far nothing. Emailed EROS Investor Relations for an update but they couldn't be bothered to respond.Maybe I've got it wrong and results weren't due but if they were but haven't been then that's a cause for concern?? |
Posted at 18/7/2016 17:47 by smurfy2001 bishan bedi -Email: vanisha.dhimer@erosi I have also emailed her more the merrier. Apparently it's upto EROS. There are no options via the broker unless EROS turnaround and allow the stock to be traded via CREST. My next step is the financial ombudsman. Luckily my investment is nothing to lose sleep over but l don't understand why they were not transferred to certified form as per note in the FAQ "At such time, shareholders who continue to hold our A ordinary shares through CREST will either receive certificated shares or, if eligible, may wish to transfer the shares into U.S. brokerage accounts." Waiting for a response from EROS. |
Posted at 10/12/2015 21:53 by michael156 Even some of the staunch "Anti's" are changing their spots slowly to standing on the fence - Interesting read....Orange Peel Investments Long/short equity Profile| Send Message| You Just Can't Own Eros Here Dec. 9, 2015 3:07 PM ET | 4 comments | About: Eros International Plc (EROS) Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. (More...) Summary •Controversy over EROS includes questions about its accounting, cash flow and film library. •Numerous larger investors have recently increased stakes in the company. •The information provided by both bulls and bears leads us to inconclusive results; while we don't see reward shorting here, we think EROS must be avoided for the time being. By Parke Shall with Thom Lachenmann I always bring Thom in with me when I'm looking at a company that's being questioned by short sellers. He can provide the balance I need to make sure that I'm seeing both sides objectively. Eros International (NYSE:EROS) is a case where we've talked about the company for weeks now amongst ourselves, initially concluding it's an outright fraud, but now pulling back our conclusions to a point where it's going to depend on the company's coming results. The controversy over EROS over the last few months has caused shares to decline almost 66% to levels where they now sit, around $10 per share. For weeks, short sellers, led by Seeking Alpha's own Alpha Exposure, have been alleging that EROS is hiding something from shareholders, noting the company's ballooning accounts receivable, lack of cash flow, and inconsistent labeling of its films. To read Alpha Exposure's full analysis, you can click here and scroll through their articles. We have read all of the critical reports as well as the commentary on Twitter and other social networking financial sites. We've also read all of the company's responses and the corresponding financial statements that have been called into question. The reason that we are commenting on EROS is that a number of institutional investors have raised their stakes in the company over the last week, prompting us to once again look at the story. We want to look at all of the items in question and try and draw a reasonable conclusion one way or the other. What we have discovered is that we do not believe there is a trade or an investment here at this point, long or short, and that we think investors may be better served waiting for more information to come out before getting involved with EROS. One large allegation made against the company was that its full list of films was incomplete and that some films were missing, potentially causing a spot for the company to inflate its revenue or obfuscate its operations from the public. After this controversy, the company provided a list of its films on its website and early accusations were later modified and revised to move from a "large number of films missing" to "smaller number of films missing." For the most part, we consider the film list allegation to have been at least partially debunked, as many of the smaller films in question continue to seem like they have no material effect on the business. It was also alleged that some movies were released well before EROS had claimed they had been. The company's explanation for the listing of its films and the corresponding years not matching up was that some movies were released before they were distributed by EROS. This seems to be a reasonable response. Whether it's true or not still remains to be seen. Naturally, accounts receivable is an area under scrutiny because it becomes a spot where the company could potentially hide revenue that it has booked but has not collected. Furthermore, the DSO number has been called into question numerous times as well. At best, this shows a company where the quality of earnings is poor, and at worst, allegations may be correct or partially correct that these revenues may never be collected on at all. We are interested in seeing a few more quarters worth of data before we make up our mind. The company has made some promises for the next two quarters, and we want to see how those pan out. The interesting thing about larger investors raising their stakes in the company is that these investors have no doubt been subject to some of the criticism that the company has seen over the past few months. There have been numerous articles written, not just on blog websites, but also from reputable news sources like Bloomberg, questioning the company's integrity and noting that other investors have shied away from EROS due to the opacity of the company's financials. The company also made some very strong statements at a conference several weeks ago, stating that it expects to be free cash flow positive by the end of the year and that it also expects to reduce the days sales outstanding and collect on some of the company's receivables. We're anxiously awaiting to see if this happens. If it doesn't in the next 2 quarters, EROS could be in real trouble. Another area that we haven't been satisfied with yet is the company's auditor. It's been argued by the short side that the company's auditor hasn't touched the financials since 2012 and has only audited subsidiaries of the company. We are looking for bona fide proof that Grant Thornton India has audited all of the financial statements. Until we see this, we're going to continue to leave this question up in the air, unanswered. Long or short, we just do not feel as if there is enough risk or reward in either direction with the stock trading at about $10. We are not convinced that the company is an outright slam dunk fraud, nor are we convinced that the company is operating legitimately. The ballooning accounts receivable is a big concern, as is the company missing estimates now that increased scrutiny has been placed upon it. We are watching the story closely and we plan on updating our thesis as more facts come to light. For now, until more facts come out, we think you can't own EROS. |
Posted at 30/10/2015 19:16 by eurofox SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Eros International Plc.EROS INTERNATIONAL PLC (NYSE:EROS) Intraday Stock Chart Today : Friday 30 October 2015 Click Here for more EROS INTERNATIONAL PLC Charts. NEW YORK, Oct. 30, 2015 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Eros International Plc. ("EROS" or the "Company") (NYSE: EROS -News). Such investors are advised to contact Peretz Bronstein or his investor relations coordinator Eitan Kimelman at info@bgandg.com or 212-697-6484. The investigation concerns whether EROS and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. On October 30, 2015, the investment blog Alpha Exposure published a report titled "Unlike the name, investors should not love EROS." The Alpha Exposure report stated, in part, that: (1) "EROS' reported earnings are significantly overstating the economic reality of its business model" as a result of the company's "aggressive accounting practices"; (2) "EROS subsidiary financials reveal a lack of free cash flow and raise many questions about the company's accounting"; and (3) "EROS has enriched its controlling family at the expense of shareholders through a series of related party transactions." Following this news, shares of EROS fell $1.29, or 10.03%, during intraday trading to trade at $11.57 on October 30, 2015. If you are aware of any facts relating to this investigation, or purchased shares of EROS, you can assist this investigation by contacting Peretz Bronstein or his Investor Relations Coordinator Eitan Kimelman of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email info@bgandg.com. Those who inquire by e-mail are encouraged to include their mailing address, email and telephone number. Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes. Contact: Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Eitan Kimelman 212-697-6484 info@bgandg.com |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
